IA
MDGL icon

IFP Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

IFP Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$253K Buy
472
+16
+4% +$8.2K ﹤0.01% 1377
2026
Q1 		$239K Sell
456
-5
-1% -$2.39K ﹤0.01% 1295
2025
Q4 		$268K Buy
461
+90
+24% +$46K 0.01% 1219
2025
Q3 		$170K Buy
371
+19
+5% +$7.09K ﹤0.01% 1366
2025
Q2 		$117K Sell
352
-17
-5% -$5.07K ﹤0.01% 1546
2025
Q1 		$122K Buy
369
+13
+4% +$4.27K ﹤0.01% 1417
2024
Q4 		$110K Buy
356
+12
+3% +$3.38K ﹤0.01% 1423
2024
Q3 		$73K Buy
344
+3
+0.9% +$767 ﹤0.01% 1551
2024
Q2 		$95.5K Buy
+341
New +$81.2K ﹤0.01% 1390
2021
Q3 		– Sell
-1
Closed – – 3421
2021
Q2 		$0 Buy
+1
New +$118 ﹤0.01% 3152

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IFP Advisors's MDGL Position: Q2 2026 in Review

IFP Advisors increased its Madrigal Pharmaceuticals (MDGL) stake by 3.5% in Q2 2026, buying an estimated $8.2K and bringing the position to 472 shares worth $253K. The position accounts for ﹤0.01% of the portfolio, ranked #1377.

IFP Advisors first reported a position in MDGL in Q2 2021 and has held it in 10 quarters since. The position peaked at $268K in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • IFP Advisors held 472 shares of Madrigal Pharmaceuticals worth $253K as of Q2 2026.
  • IFP Advisors bought 16 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $8.2K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #1377 holding.
  • IFP Advisors first reported a position in Madrigal Pharmaceuticals in Q2 2021 and has held it in 10 quarters since.
  • IFP Advisors's Madrigal Pharmaceuticals position peaked at $268K in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.